TITLE

Lamisil AT

AUTHOR(S)
Goetzl, David
PUB. DATE
June 2000
SOURCE
Advertising Age;6/26/2000, Vol. 71 Issue 27, ps26
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Discusses an advertising campaign for Novartis Consumer Health's athlete's foot cream Lamisil AT. How Grey Advertising's Barry Cohen handled the project, through which Lamisil became the top selling athlete's foot remedy; One-year sales totals; Cohen's use of professional basketball player Grant Hill to promote the product.
ACCESSION #
3250388

 

Related Articles

  • Athlete's foot remedy leaps over counter. Goetzl, David // Advertising Age;5/10/1999, Vol. 70 Issue 10, p8 

    This article reports on a marketing effort for a new over-the-counter athlete's foot treatment launched by Novartis Consumer Health as of May 10, 1999. The $15 million to $20 million TV and print effort for Lamisil AT features energetic, sculpted athletes playing basketball, running, biking and...

  • Novartis sees quick results with OTC Lamisil. Goetzl, David // Advertising Age;6/28/1999, Vol. 70 Issue 27, p12 

    Reports on the success of Novartis Consumer Health's athlete's foot remedy, Lamisil AT, which was a prescription product switched to over-the-counter (OTC) status in the United States. Cost of the Grey Advertising television and print campaign for Lamisil; Comment of Barry Cohen Novartis'...

  • NOVARTIS CONSUMER HEALTH LAUNCHED. M. A. // Medical Marketing & Media;Dec2009, Vol. 44 Issue 12, p11 

    The article offers information on the launch of the advertisement for OTC Prevacid with a 200 million dollars marketing campaign by Novartis Consumer Health Inc.

  • Latest switch--Lamisil--offers to get it done faster. Levy, Sandra // Drug Topics;4/19/99, Vol. 143 Issue 8, p72 

    Announces the United States Food and Drug Administration's approval of Lamisil Cream 1% terbinafine cream, a treatment for athlete's foot from Novartis Consumer Health. Lamisil's switch to become an over-the-counter (OTC) drug; Budget for consumer campaign focusing on the medication's claim...

  • Lamisil cream makes OTC switch.  // Drug Topics;4/5/99, Vol. 143 Issue 7, p7 

    Reports that the United States Food and Drug Administration (FDA) has approved Novartis Consumer Health to switch Lamisil cream from Rx drug status to OTC status for the treatment of athlete's foot.

  • Novartis moots pooling ...5m Ovaltine brief in Euro review.  // Marketing Week;5/11/2000, Vol. 23 Issue 15, p13 

    Reports that Novartis Consumer Health is considering consolidating its British and European Ovaltine-drink advertising accounts into one agency. Agencies handling each account; Novartis' assignment of another project to Young & Rubicam to transfer best practice from Europe to Great Britain.

  • New dietary supplement products on the way. Levy, Sandra // Drug Topics;6/4/2001, Vol. 145 Issue 11, p31 

    Presents information on Resource Wellness, a line of dietary supplements from Novartis Consumer Health. Reasons for launching the product despite weak sales of dietary supplements; Description of the products; Advertising campaigns for the products.

  • Hotline.  // Campaign;01/08/99, Issue 1, p3 

    Reports that CIA Medianetwork has won the international over-the-counter media account of the drug company, Novartis Consumer Health, in Europe.

  • Novartis painkiller to back ITV's The Royal. Carter, Ben // Marketing (00253650);11/24/2004, p9 

    This article reports that Novartis Consumer Health Inc.has signed up to become the first broadcast sponsor of ITV hospital drama the Royal to build awareness of its Voltarol Emugel P painkiller. The deal, thought to be worth close to £1m, marks Voltarol's first foray into TV sponsorship and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics